Sumiko Shingo

893 total citations
18 papers, 699 citations indexed

About

Sumiko Shingo is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Sumiko Shingo has authored 18 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Pharmacology. Recurrent topics in Sumiko Shingo's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Sumiko Shingo is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Sumiko Shingo collaborates with scholars based in United States, Belgium and Netherlands. Sumiko Shingo's co-authors include Theodore F. Reiss, T.F. Reiss, Beth S. Friedman, Zev M. Munk, James M. Seltzer, Ji Zhang, Leonard C. Altman, Alise Reicin, Wesley Tanaka and Reynold Spector and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Sumiko Shingo

18 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumiko Shingo United States	14	440	331	165	138	86	18	699
Aditi Shahane United States	6	252 0.6×	159 0.5×	313 1.9×	86 0.6×	121 1.4×	11	597
Ha Nguyen United States	9	417 0.9×	364 1.1×	44 0.3×	114 0.8×	67 0.8×	12	735
Ed J. Hendricks United States	8	104 0.2×	71 0.2×	217 1.3×	33 0.2×	61 0.7×	13	456
Rosa‐Maria Guéant‐Rodriguez France	14	167 0.4×	48 0.1×	186 1.1×	149 1.1×	77 0.9×	20	704
Sarah Walker Australia	11	119 0.3×	67 0.2×	58 0.4×	40 0.3×	40 0.5×	13	436
Ricardo Tan United States	15	384 0.9×	237 0.7×	15 0.1×	164 1.2×	134 1.6×	31	758
G Cremonesi Italy	12	216 0.5×	182 0.5×	31 0.2×	20 0.1×	30 0.3×	31	414
Senshu Hifumi Japan	9	156 0.4×	85 0.3×	26 0.2×	11 0.1×	52 0.6×	20	393
Gabriella Passacquale United Kingdom	15	68 0.2×	48 0.1×	74 0.4×	23 0.2×	108 1.3×	22	743
Victoria Korley Canada	13	119 0.3×	75 0.2×	38 0.2×	42 0.3×	52 0.6×	22	726

Countries citing papers authored by Sumiko Shingo

Since Specialization

Citations

This map shows the geographic impact of Sumiko Shingo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumiko Shingo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumiko Shingo more than expected).

Fields of papers citing papers by Sumiko Shingo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumiko Shingo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumiko Shingo. The network helps show where Sumiko Shingo may publish in the future.

Co-authorship network of co-authors of Sumiko Shingo

This figure shows the co-authorship network connecting the top 25 collaborators of Sumiko Shingo. A scholar is included among the top collaborators of Sumiko Shingo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumiko Shingo. Sumiko Shingo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Malmström, Kerstin, et al.. (2005). The analgesic effect of etoricoxib relative to that of two opioid-acetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain. Current Medical Research and Opinion. 21(1). 141–149. 22 indexed citations

Tsoukas, Christos, M. Elaine Eyster, Sumiko Shingo, et al.. (2005). Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood. 107(5). 1785–1790. 44 indexed citations

Curtis, Sean, Jennifer Ng, Qinfen Yu, et al.. (2004). Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials. Clinical Therapeutics. 26(1). 70–83. 49 indexed citations

Sfikakis, P.P., Lisa DeTora, Sumiko Shingo, et al.. (2002). A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology. 31(4). 230–238. 30 indexed citations

Shingo, Sumiko, et al.. (2002). A Standardized Composite Clinical Score for Inhaled Corticosteroids Taper Studies in Asthma. Drug Information Journal. 36(3). 501–508. 4 indexed citations

Shingo, Sumiko, et al.. (2001). Correlation of airway obstruction and patient-reported endpoints in clinical studies. European Respiratory Journal. 17(2). 220–224. 67 indexed citations

Storms, William W., Theresa M. Michele, Barbara Knorr, et al.. (2001). Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years. Clinical & Experimental Allergy. 31(1). 77–87. 71 indexed citations

Barnes, Neil, Lynn Wei, Theodore F. Reiss, et al.. (2001). Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Respiratory Medicine. 95(5). 379–386. 27 indexed citations

Altman, Leonard C., Zev M. Munk, James M. Seltzer, et al.. (1998). A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist. Journal of Allergy and Clinical Immunology. 102(1). 50–56. 127 indexed citations

10.

Malmström, Kerstin, Jules I. Schwartz, Theodore F. Reiss, et al.. (1998). Effect of Montelukast on Single-Dose Theophylline Pharmacokinetics. American Journal of Therapeutics. 5(3). 189–196. 15 indexed citations

11.

Hillingsø, Jens, Jens Kjeldsen, Laurits S. Laursen, et al.. (1995). Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. Clinical Pharmacology & Therapeutics. 57(3). 335–341. 17 indexed citations

12.

Friedman, Beth S., Anne Van Hecken, Inge De Lepeleire, et al.. (1994). Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase—activating protein inhibitor. Clinical Pharmacology & Therapeutics. 56(1). 22–30. 16 indexed citations

13.

McCrea, Jacqueline B., Richard J. Fruncillo, Sherry D. Holland, et al.. (1993). Lovastatin Does Not Affect Oral Glucose Tolerance in Hypercholesterolemic Patients. The Journal of Clinical Pharmacology. 33(6). 581–585. 4 indexed citations

14.

Murphy, M. Gail, Thomas O. Kovacs, Howard Mertz, et al.. (1993). The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans. Clinical Pharmacology & Therapeutics. 54(5). 533–539. 27 indexed citations

15.

Reiss, Theodore F., et al.. (1993). Acute Bronchodilation with an Intravenously Administered Leukotriene D ₄ Antagonist, MK-679. American Review of Respiratory Disease. 147(6_pt_1). 1442–1446. 44 indexed citations

16.

Laskin, Oscar L., et al.. (1993). Pharmacodynamics and Dose‐Response Relationship of Famotidine: A Double‐Blind Randomized Placebo‐Controlled Trial. The Journal of Clinical Pharmacology. 33(7). 636–639. 7 indexed citations

17.

Friedman, Beth S., A. Buntinx, Wesley Tanaka, et al.. (1993). Oral Leukotriene Inhibitor (MK-886) Blocks Allergen-induced Airway Responses. American Review of Respiratory Disease. 147(4). 839–844. 126 indexed citations

18.

Zhang, Ji, Sumiko Shingo, Theodore F. Reiss, Beth S. Friedman, & Thomas Capizzi. (1993). P44 Statistical issues in the design and analysis of clinical trials evaluating therapy for chronic asthma. Controlled Clinical Trials. 14(5). 445–445. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact